-
EP4570249
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP4570249
| EP4570249 - USE OF PIPERAZINE COMPOUND IN COMBINATION WITH RADIOTHERAPY FOR TREATMENT OF TUMOR [Right-click to bookmark this link] | Status | Request for examination was made Status updated on 16.05.2025 Database last updated on 21.03.2026 | |
| Former | The international publication has been made Status updated on 20.02.2024 | Most recent event Tooltip | 10.10.2025 | Change: Validation states | published on 12.11.2025 [2025/46] | 10.10.2025 | Change - extension states | published on 12.11.2025 [2025/46] | Applicant(s) | For all designated states Kangbaida (Sichuan) Biotechnology Co., Ltd. No.433, Anxian Road Section 3, Knight Avenue Wenjiang District Chengdu, Sichuan 610000 / CN | [2025/25] | Inventor(s) | 01 /
ZHU, Yuqin Chengdu, Sichuan 610000 / CN | 02 /
WEI, Yonggang Chengdu, Sichuan 610000 / CN | 03 /
CHU, Hongzhu Chengdu, Sichuan 610000 / CN | 04 /
YE, Fei Chengdu, Sichuan 610000 / CN | 05 /
SU, Guizhuan Chengdu, Sichuan 610000 / CN | 06 /
SUN, Yi Chengdu, Sichuan 610000 / CN | [2025/25] | Representative(s) | Kador & Partner Part mbB Corneliusstraße 15 80469 München / DE | [2025/25] | Application number, filing date | 23851630.6 | 31.07.2023 | [2025/25] | WO2023CN110230 | Priority number, date | CN202210949131 | 09.08.2022 Original published format: CN202210949131 | [2025/25] | Filing language | ZH | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2024032409 | Date: | 15.02.2024 | Language: | ZH | [2024/07] | Type: | A1 Application with search report | No.: | EP4570249 | Date: | 18.06.2025 | Language: | EN | [2025/25] | Search report(s) | International search report - published on: | CN | 15.02.2024 | Classification | IPC: | A61K31/4985, C07D471/04, A61P35/00 | [2025/25] | CPC: |
A61P35/00 (EP,KR,US);
C07D487/04 (EP,KR);
A61K31/5377 (US);
A61K31/4985 (KR);
A61K31/501 (EP,US);
A61K31/506 (EP,US);
A61K31/519 (US);
A61N5/00 (US);
C07D471/04 (EP,KR);
C07D487/10 (KR)
(-)
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, ME, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2025/25] | Title | German: | VERWENDUNG EINER PIPERAZINVERBINDUNG IN KOMBINATION MIT STRAHLENTHERAPIE ZUR BEHANDLUNG VON TUMOREN | [2025/25] | English: | USE OF PIPERAZINE COMPOUND IN COMBINATION WITH RADIOTHERAPY FOR TREATMENT OF TUMOR | [2025/25] | French: | UTILISATION D'UN COMPOSÉ PIPÉRAZINE EN ASSOCIATION AVEC UNE RADIOTHÉRAPIE POUR LE TRAITEMENT D'UNE TUMEUR | [2025/25] | Entry into regional phase | 07.02.2025 | Translation filed | 07.02.2025 | National basic fee paid | 07.02.2025 | Search fee paid | 07.02.2025 | Designation fee(s) paid | 07.02.2025 | Examination fee paid | Examination procedure | 07.02.2025 | Amendment by applicant (claims and/or description) | 07.02.2025 | Examination requested [2025/25] | Fees paid | Renewal fee | 07.02.2025 | Renewal fee patent year 03 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | |||